4-(Trifluoromethyl)cyclohexanol, cis/trans, 97.0%, 5g

4,5-dimethylthiophene-3-carboxylic acid, 95.0%, 500mg

tert-Butyl (2-bromothiazol-4-yl)carbamate, 95.0%, 25g

7-Methoxynaphthalen-1-ol, 95.0%, 2.5g

Piperidin-4-ol hydrochloride, 95.0%, 100g

3-bromo-4-chloro-1H-pyrazolo[3,4-b]pyridine, 95%, 250mg

GC capillary column ROTI®Cap-FFAP, 60 m, 0.32 mm, 0.25 µm, 1 Piece(s)

(2E)-1-(2,4-dimethoxyphenyl)-3-(3-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

5,7-DIHYDROX -4'-METHOXYISOFLAVONE, 95.0%, 25g

Mal-PEG3-NHS ester, 1g

3-Bromo-2,6-difluorobenzoic acid, 97.0%, 1g

4-(Chloromethyl)oxazole, 95.0%, 250mg

5-(4-Bromophenyl)-2-furaldehyde>94.0%(GC)5g